Accentia Biopharmaceuticals Inc Stock

Stocks

12/09/12	Accentia Biopharmaceuticals Inc : Biovest Names Lymphoma Key Opinion Leader from MD Anderson Cancer Center to Scientific Advisory Board	PU
13/07/12	Accentia Biopharmaceuticals Inc : Biovest’s Eligibility to Seek EU Marketing Approval for its BiovaxID Cancer Vaccine as Orphan Drug Confirmed by EMA	PU
30/05/12	Accentia Biopharmaceuticals Inc : Biovest Names Dr. Eduardo Sotomayor, Chair of Dept of Malignant Hematology at Moffitt Cancer Center, to its Scientific Advisory Board	PU
19/05/12	Accentia Biopharmaceuticals Inc : Biovest Announces BiovaxID® ASCO Abstract Available On-line; NCI to Present Cancer Vaccine Data from Mantle Cell Lymphoma Study	PU
16/05/12	Accentia Biopharmaceuticals Inc : Biovest Retains Ferghana Partners to Evaluate Strategic Transactions	PU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACCENTIA BIOPHARMACEUTICALS INC	-.--%	-.--%	-	-	0
LONZA GROUP AG	+1.44%	+1.71%	-10.98%	-6.19%	43.13B
REVOLUTION MEDICINES, INC.	+3.31%	+5.93%	+310.97%	+534.70%	34.65B
BEONE MEDICINES AG	+2.84%	+2.14%	+9.34%	+41.02%	30.03B
IQVIA HOLDINGS INC.	-1.70%	-7.54%	+8.43%	-21.94%	28B
CELLTRION, INC.	-1.90%	-1.56%	+10.24%	+21.21%	24.45B
ASCENDIS PHARMA A/S	-0.14%	+5.86%	-	-	14.34B
MEDPACE HOLDINGS, INC.	+0.68%	-1.53%	+48.76%	+104.27%	13.14B
EUROFINS SCIENTIFIC SE	-0.57%	-2.43%	+5.08%	+4.79%	12.53B
IONIS PHARMACEUTICALS, INC.	-0.26%	+1.15%	+98.13%	+80.47%	12.25B
Average	+0.37%	+0.73%	+60.00%	+94.79%	23.61B
Weighted average by Cap.	+0.77%	+1.27%	+65.47%	+110.06%